BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34819374)

  • 21. Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity.
    Li KJ; Wu CH; Lu CH; Shen CY; Kuo YM; Tsai CY; Hsieh SC; Yu CL
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colon cancer and the immune system: the role of tumor invading T cells.
    Waldner M; Schimanski CC; Neurath MF
    World J Gastroenterol; 2006 Dec; 12(45):7233-8. PubMed ID: 17143936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.
    Lin YC; Mahalingam J; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Chiu CT; Lin CY
    Int J Cancer; 2013 Mar; 132(6):1341-50. PubMed ID: 22907255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.
    Vo MC; Lee HJ; Kim JS; Hoang MD; Choi NR; Rhee JH; Lakshmanan VK; Shin SJ; Lee JJ
    Oncotarget; 2015 Oct; 6(32):33781-90. PubMed ID: 26418952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
    Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells.
    Hudrisier D; Aucher A; Puaux AL; Bordier C; Joly E
    J Immunol; 2007 Mar; 178(6):3637-47. PubMed ID: 17339461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
    Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
    PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
    Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J
    Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polysaccharide from
    Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
    Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses.
    Ghasemi-Chaleshtari M; Kiaie SH; Irandoust M; Karami H; Nabi Afjadi M; Ghani S; Aghaei Vanda N; Ghaderi Sede MJ; Ahmadi A; Masjedi A; Hassannia H; Atyabi F; Hojjat-Farsangi M; Namdar A; Ghalamfarsa G; Jadidi-Niaragh F
    J Cell Physiol; 2020 Dec; 235(12):10068-10080. PubMed ID: 32488862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capture of plasma membrane fragments from target cells by trogocytosis requires signaling in T cells but not in B cells.
    Aucher A; Magdeleine E; Joly E; Hudrisier D
    Blood; 2008 Jun; 111(12):5621-8. PubMed ID: 18381976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes.
    Horn LA; Long TM; Atkinson R; Clements V; Ostrand-Rosenberg S
    Cancer Immunol Res; 2018 Jan; 6(1):59-68. PubMed ID: 29122838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses.
    Zhao X; Yuan C; Wangmo D; Subramanian S
    Gastroenterology; 2021 Aug; 161(2):560-574.e11. PubMed ID: 33895168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
    Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.
    Chen X; Hamano R; Subleski JJ; Hurwitz AA; Howard OM; Oppenheim JJ
    J Immunol; 2010 Jul; 185(1):174-82. PubMed ID: 20525892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells.
    Feng PH; Lam B; Tseng SH; Kung YJ; Farmer E; Cheng MA; Hung CF
    Cancer Immunol Immunother; 2020 Oct; 69(10):2147-2155. PubMed ID: 32468232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer.
    Hasim MS; Marotel M; Hodgins JJ; Vulpis E; Makinson OJ; Asif S; Shih HY; Scheer AK; MacMillan O; Alonso FG; Burke KP; Cook DP; Li R; Petrucci MT; Santoni A; Fallon PG; Sharpe AH; Sciumè G; Veillette A; Zingoni A; Gray DA; McCurdy A; Ardolino M
    Sci Adv; 2022 Apr; 8(15):eabj3286. PubMed ID: 35417234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.